US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 459.000
  • -3.580-0.77%
Close Feb 14 16:00 ET
  • 462.910
  • +3.910+0.85%
Pre 04:26 ET
117.87BMarket Cap-220.67P/E (TTM)

Vertex Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
11.66%11.02B
15.66%2.91B
11.61%2.77B
6.11%2.65B
13.30%2.69B
10.51%9.87B
9.34%2.52B
6.39%2.48B
13.52%2.49B
13.22%2.37B
Operating revenue
11.66%11.02B
15.66%2.91B
11.61%2.77B
6.11%2.65B
13.30%2.69B
10.51%9.87B
9.34%2.52B
6.39%2.48B
13.52%2.49B
13.22%2.37B
Cost of revenue
21.26%1.53B
15.05%423.4M
23.19%392.6M
20.51%371.9M
28.36%342.6M
16.84%1.26B
29.90%368M
10.12%318.7M
17.88%308.6M
8.58%266.9M
Gross profit
10.25%9.49B
15.76%2.49B
9.91%2.38B
4.08%2.27B
11.39%2.35B
9.64%8.61B
6.45%2.15B
5.86%2.16B
12.93%2.18B
13.84%2.11B
Operating expense
18.49%5.09B
15.30%1.38B
16.19%1.25B
27.71%1.34B
15.06%1.13B
23.37%4.3B
24.15%1.19B
20.41%1.07B
28.56%1.05B
20.51%983.7M
Selling and administrative expenses
28.83%1.46B
2.30%377.6M
40.94%371.8M
41.74%372.2M
42.14%342.7M
20.31%1.14B
38.03%369.1M
6.89%263.8M
21.97%262.6M
12.04%241.1M
Research and development costs
14.78%3.63B
21.11%998.7M
8.14%875.9M
23.02%966.6M
6.26%789.1M
24.51%3.16B
18.80%824.6M
25.58%810M
30.93%785.7M
23.54%742.6M
Operating profit
2.03%4.4B
16.35%1.11B
3.72%1.13B
-17.72%934.9M
8.18%1.22B
-1.33%4.31B
-9.63%956M
-5.39%1.09B
1.55%1.14B
8.58%1.12B
Net non-operating interest income expense
-0.54%567.5M
-25.75%125.4M
-20.57%124.7M
9.81%146.6M
53.60%170.8M
535.41%570.6M
127.02%168.9M
383.08%157M
3,613.16%133.5M
936.09%111.2M
Non-operating interest income
-2.70%598.1M
-28.58%128.2M
-21.26%132.2M
8.15%156.5M
47.80%181.2M
325.10%614.7M
108.72%179.5M
263.42%167.9M
1,239.81%144.7M
7,562.50%122.6M
Non-operating interest expense
-30.61%30.6M
-73.58%2.8M
-31.19%7.5M
-11.61%9.9M
-8.77%10.4M
-19.53%44.1M
-8.62%10.6M
-20.44%10.9M
-23.29%11.2M
-23.49%11.4M
Other net income (expense)
-846.02%-4.71B
-545.81%-101.2M
53.20%-32.2M
-4,029.92%-4.47B
68.62%-107.9M
-123.65%-498.3M
140.90%22.7M
-647.83%-68.8M
-19.27%-108.3M
-411.00%-343.9M
Special income (charges)
-873.27%-4.63B
-365.54%-86.3M
71.08%-15.3M
-3,948.77%-4.45B
77.78%-76.7M
-719.83%-475.5M
233.20%32.5M
-100.38%-52.9M
-765.35%-109.9M
-6,376.36%-345.2M
-Less：Restructuring and merger&acquisition
99.03%-500K
97.61%-1.2M
-75.00%300K
183.33%500K
94.74%-100K
10.26%-51.6M
-2,894.44%-50.3M
146.15%1.2M
98.78%-600K
74.67%-1.9M
-Less:Other special charges
778.09%4.63B
391.57%87.5M
-70.99%15M
3,926.33%4.45B
-77.87%76.8M
356.36%527.1M
-21.24%17.8M
78.28%51.7M
78.51%110.5M
17,255.00%347.1M
Other non- operating income (expenses)
-277.63%-86.1M
-52.04%-14.9M
-6.29%-16.9M
-1,543.75%-23.1M
-2,500.00%-31.2M
86.17%-22.8M
68.49%-9.8M
-192.44%-15.9M
102.05%1.6M
101.79%1.3M
Income before tax
-94.33%248.5M
-0.97%1.14B
3.81%1.22B
-391.97%-3.39B
43.48%1.28B
3.48%4.38B
6.58%1.15B
0.24%1.18B
13.38%1.16B
-6.63%891.5M
Income tax
3.14%784.1M
25.00%223.5M
24.18%178.7M
-17.66%202.4M
-6.36%179.5M
-16.50%760.2M
-30.67%178.8M
-41.48%143.9M
14.91%245.8M
-0.52%191.7M
Net income
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
8.96%3.62B
18.31%968.8M
11.26%1.04B
12.98%915.7M
-8.17%699.8M
Net income continuous Operations
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
8.96%3.62B
18.31%968.8M
11.26%1.04B
12.98%915.7M
-8.17%699.8M
Minority interest income
Net income attributable to the parent company
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
8.96%3.62B
18.31%968.8M
11.26%1.04B
12.98%915.7M
-8.17%699.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-114.80%-535.6M
-5.76%913M
0.98%1.05B
-492.44%-3.59B
57.13%1.1B
8.96%3.62B
18.31%968.8M
11.26%1.04B
12.98%915.7M
-8.17%699.8M
Basic earnings per share
-114.80%-2.08
-5.59%3.55
1.00%4.05
-492.11%-13.92
56.62%4.26
8.33%14.05
17.87%3.76
10.47%4.01
11.99%3.55
-9.03%2.72
Diluted earnings per share
-114.97%-2.08
-5.66%3.5
1.01%4.01
-495.45%-13.92
56.51%4.21
8.35%13.89
17.78%3.71
10.58%3.97
12.46%3.52
-9.12%2.69
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 11.66%11.02B15.66%2.91B11.61%2.77B6.11%2.65B13.30%2.69B10.51%9.87B9.34%2.52B6.39%2.48B13.52%2.49B13.22%2.37B
Operating revenue 11.66%11.02B15.66%2.91B11.61%2.77B6.11%2.65B13.30%2.69B10.51%9.87B9.34%2.52B6.39%2.48B13.52%2.49B13.22%2.37B
Cost of revenue 21.26%1.53B15.05%423.4M23.19%392.6M20.51%371.9M28.36%342.6M16.84%1.26B29.90%368M10.12%318.7M17.88%308.6M8.58%266.9M
Gross profit 10.25%9.49B15.76%2.49B9.91%2.38B4.08%2.27B11.39%2.35B9.64%8.61B6.45%2.15B5.86%2.16B12.93%2.18B13.84%2.11B
Operating expense 18.49%5.09B15.30%1.38B16.19%1.25B27.71%1.34B15.06%1.13B23.37%4.3B24.15%1.19B20.41%1.07B28.56%1.05B20.51%983.7M
Selling and administrative expenses 28.83%1.46B2.30%377.6M40.94%371.8M41.74%372.2M42.14%342.7M20.31%1.14B38.03%369.1M6.89%263.8M21.97%262.6M12.04%241.1M
Research and development costs 14.78%3.63B21.11%998.7M8.14%875.9M23.02%966.6M6.26%789.1M24.51%3.16B18.80%824.6M25.58%810M30.93%785.7M23.54%742.6M
Operating profit 2.03%4.4B16.35%1.11B3.72%1.13B-17.72%934.9M8.18%1.22B-1.33%4.31B-9.63%956M-5.39%1.09B1.55%1.14B8.58%1.12B
Net non-operating interest income expense -0.54%567.5M-25.75%125.4M-20.57%124.7M9.81%146.6M53.60%170.8M535.41%570.6M127.02%168.9M383.08%157M3,613.16%133.5M936.09%111.2M
Non-operating interest income -2.70%598.1M-28.58%128.2M-21.26%132.2M8.15%156.5M47.80%181.2M325.10%614.7M108.72%179.5M263.42%167.9M1,239.81%144.7M7,562.50%122.6M
Non-operating interest expense -30.61%30.6M-73.58%2.8M-31.19%7.5M-11.61%9.9M-8.77%10.4M-19.53%44.1M-8.62%10.6M-20.44%10.9M-23.29%11.2M-23.49%11.4M
Other net income (expense) -846.02%-4.71B-545.81%-101.2M53.20%-32.2M-4,029.92%-4.47B68.62%-107.9M-123.65%-498.3M140.90%22.7M-647.83%-68.8M-19.27%-108.3M-411.00%-343.9M
Special income (charges) -873.27%-4.63B-365.54%-86.3M71.08%-15.3M-3,948.77%-4.45B77.78%-76.7M-719.83%-475.5M233.20%32.5M-100.38%-52.9M-765.35%-109.9M-6,376.36%-345.2M
-Less：Restructuring and merger&acquisition 99.03%-500K97.61%-1.2M-75.00%300K183.33%500K94.74%-100K10.26%-51.6M-2,894.44%-50.3M146.15%1.2M98.78%-600K74.67%-1.9M
-Less:Other special charges 778.09%4.63B391.57%87.5M-70.99%15M3,926.33%4.45B-77.87%76.8M356.36%527.1M-21.24%17.8M78.28%51.7M78.51%110.5M17,255.00%347.1M
Other non- operating income (expenses) -277.63%-86.1M-52.04%-14.9M-6.29%-16.9M-1,543.75%-23.1M-2,500.00%-31.2M86.17%-22.8M68.49%-9.8M-192.44%-15.9M102.05%1.6M101.79%1.3M
Income before tax -94.33%248.5M-0.97%1.14B3.81%1.22B-391.97%-3.39B43.48%1.28B3.48%4.38B6.58%1.15B0.24%1.18B13.38%1.16B-6.63%891.5M
Income tax 3.14%784.1M25.00%223.5M24.18%178.7M-17.66%202.4M-6.36%179.5M-16.50%760.2M-30.67%178.8M-41.48%143.9M14.91%245.8M-0.52%191.7M
Net income -114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B8.96%3.62B18.31%968.8M11.26%1.04B12.98%915.7M-8.17%699.8M
Net income continuous Operations -114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B8.96%3.62B18.31%968.8M11.26%1.04B12.98%915.7M-8.17%699.8M
Minority interest income
Net income attributable to the parent company -114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B8.96%3.62B18.31%968.8M11.26%1.04B12.98%915.7M-8.17%699.8M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -114.80%-535.6M-5.76%913M0.98%1.05B-492.44%-3.59B57.13%1.1B8.96%3.62B18.31%968.8M11.26%1.04B12.98%915.7M-8.17%699.8M
Basic earnings per share -114.80%-2.08-5.59%3.551.00%4.05-492.11%-13.9256.62%4.268.33%14.0517.87%3.7610.47%4.0111.99%3.55-9.03%2.72
Diluted earnings per share -114.97%-2.08-5.66%3.51.01%4.01-495.45%-13.9256.51%4.218.35%13.8917.78%3.7110.58%3.9712.46%3.52-9.12%2.69
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
HENDERA
831152
+30.00%
Hengerda New Materials
300946
+20.01%
Fujian Nebula Electronics.,Ltd
300648
+20.00%
4
Cubic Digital Technology
300344
+19.98%
5
HNAC Technology
300490
+19.95%
Log In for the Full List
Unlock Now
Investment Course
Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.
Discussing
Major earnings are approaching! What's ahead for Chinese stocks in 2025?
Recently, institutions such as Goldman Sachs, Morgan Stanley, and Appaloosa LP have spoken positively about Chinese assets. 🎙️Discussion: 1 Show More
Alibaba Group Q4 FY2024 earnings conference call
Earnings Season Underway
Earnings season is here. What to know?